Manali Parulekar

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)

Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava et al. · Journal of Clinical Oncology · 2023 · 34 citations

Medicine, Oncology, Pharmacology +17

Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer

Anant Ramaswamy, Vikas Ostwal, Atul Sharma et al. · JAMA Oncology · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

Antirelapse Efficacy of Various Primaquine Regimens for <i>Plasmodium </i><i>vivax</i>

Dimple Rajgor, Nithya Gogtay, V. S. Kadam et al. · Malaria Research and Treatment · 2014 · 26 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy

Vikas Ostwal, Anant Ramaswamy, Sarika Mandavkar et al. · JAMA Network Open · 2024 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer

Vikas Ostwal, Shraddha Patkar, Reena Engineer et al. · JAMA Oncology · 2024 · 17 citations · Full text

Medicine, Oncology, Surgery +17